NCT04196751 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Antonovsky, A
, 1987. Unravelling the mystery of health: How people manage stress and stay well. Jossey-Bass, San Francisco
Chen, G
-M., Starosta, W.J., 2000. The Development and Validation of the Intercultural Sensitivity Scale
Gonge H, Buus N
Exploring Organizational Barriers to Strengthening Clinical Supervision of Psychiatric Nursing Staff: A Longitudinal Controlled Intervention Study. Issues Ment Health Nurs. 2016 May;37(5):332-43. doi: 10.3109/01612840.2016.1154119. Epub 2016 Apr 14.
Saxby C, Wilson J, Newcombe P
Can clinical supervision sustain our workforce in the current healthcare landscape? Findings from a Queensland study of allied health professionals. Aust Health Rev. 2015 Sep;39(4):476-482. doi: 10.1071/AH14183.

An Evaluation Study to Identify the Effectiveness of Clinical Supervision With Regards to Work-related Strain, Sense of Coherence, Increased Cultural Sensitivity and the Impact on Patient's Care: A Prospective Longitudinal Study in Mental Health Services in Qatar

Details for clinical trial NCT04196751

Clinical trial NCT04196751 - References